Citation Impact
Citing Papers
No health without mental health
2007 Standout
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Haloperidol dose for the acute phase of schizophrenia
2002
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
1994 Standout
MRI correlates of treatment response in first episode psychosis
1998
Schizophrenia – a Brain Disease? a Critical Review of Structural and Functional Cerebral Abnormality in the Disorder
1995
A computerized magnetic resonance imaging study of corpus callosum morphology in schizophrenia
1993
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Effects of phencyclidine metabolites on serotonin uptake in rat brain
1996
Magnetic Resonance Imaging of the Brain in Schizophrenia
1990
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Quantitative magnetic resonance imaging of the corpus callosum in childhood onset schizophrenia
1997
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
Anatomical characteristics of the corpus callosum and clinical correlates in schizophrenia
1994
A quantitative magnetic resonance imaging study of patients with schizophrenia
1993
Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects
1999
Schizophrenia
2009 Standout
Long-Acting Risperidone
2004
Standardized magnetic resonance image intensity study in Schizophrenia
1988
Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia
1992 Standout
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
1989
Application of automated MRI volumetric measurement techniques to the ventricular system in schizophrenics and normal controls
1991
Meta-analysis of brain and cranial size in schizophrenia
1996
MRI anatomy of schizophrenia
1999
Structural and Functional Characteristics of the Corpus Callosum in Schizophrenics, Psychiatric Controls, and Normal Controls
1990
MRI abnormalities in tardive dyskinesia
1991
Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2003
Hemispheric asymmetries and schizophrenia: A preliminary magnetic resonance imaging study
1989
Prefrontal Cortex and Schizophrenia
1995
Magnetic resonance technology in human brain science: Blueprint for a program based upon morphometry
1989
Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia
1993
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
2007
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
GPCR functional selectivity has therapeutic impact
2007
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Landmark-based morphometric analysis of first-episode schizophrenia
1999
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
1988 Standout
Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products
1990
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
Quantitative Neuroanatomy in Schizophrenia
1988
A review of MRI findings in schizophrenia
2001 Standout
Correlation of Negative Symptoms in Schizophrenia with Frontal Lobe Parameters on Magnetic Resonance Imaging
1991
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia
1989
Major Depressive Disorder
2008 Standout
Corpus callosum shape and size in male patients with schizophrenia
1998
A Magnetic Resonance Imaging Study of Schizophrenia: Brain Structure and Clinical Symptoms
1991
Brain dysfunction during motor activation and corpus callosum alterations in Schizophrenia measured by cerebral blood flow and magnetic resonance imaging
1991
Whole Brain Segmentation
2002 Standout
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Anatomical Abnormalities in the Brains of Monozygotic Twins Discordant for Schizophrenia
1990
Cocaine and Other Stimulants
1988 Standout
Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance imaging study
1990
Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness
1994
Dopamine uptake: A review of progress in the last decade
1990
Withdrawal from Chronic Phencyclidine Treatment Induces Long-Lasting Depression in Brain Reward Function
2002
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Magnetic Resonance Imaging Abnormalities in Lenticular Nuclei and Cerebral Cortex in Schizophrenia
1991
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
A magnetic resonance imaging study in first‐episode disorganized‐type patients with schizophrenia
1997
Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications
2012
Diabetes and schizophrenia 2005: are we any closer to understanding the link?
2005
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Effect of the methionine analogs, ethionine and norleucine, on DNA synthesis in Escherichia coli 15T−
1968
Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioural studies
1982 StandoutNobel
The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity
1984
Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat
1984
Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: A putative selective dop amine autoreceptor agonist
1983
Cellular differentiation, cytidine analogs and DNA methylation
1980 Standout
Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation
1981
Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors
1977
Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate
1978
Self-inhibition by Dopaminergic Neurons
1975 Science
Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity
1980
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989 StandoutNobel
Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers
1983
Patterns of transfer RNA in normal rat liver and during hepatic carcinogenesis.
1967 StandoutNobel
Correlation between Hypomethylation of DNA and Expression of Globin Genes in Friend Erythroleukemia Cells
1977
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias
1983 StandoutNobel
Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists
1976
Oxidative Nucleobase Modifications Leading to Strand Scission
1998 Standout
Hyperglycemia and Diabetes in Patients With Schizophrenia or Schizoaffective Disorders
2006
Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction.
1982 StandoutNobel
Effect of diet on adenylosuccinase activity in various organs of rat and chicken.
1978
Prospective Evaluation and Classification of Ureteral Wall Injuries Resulting from Insertion of a Ureteral Access Sheath During Retrograde Intrarenal Surgery
2012 Standout
Haloperidol dose for the acute phase of schizophrenia
2013
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Avoidance and ICSS behavioral models dissociate TL-99 and 3-PPP from dopamine receptor antagonists
1983
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis
1984
Identification of the True Product of the Urate Oxidase Reaction
1997
Multiple receptors for dopamine
1979 StandoutNature
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99
1981
SCHIZOPHRENIA
1982
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Specificity of adenylosuccinate synthetase and adenylosuccinate lyase from Leishmania donovani. Selective amination of an antiprotozoal agent.
1979 StandoutNobel
Action of putative dopamine receptor agonists, TL-99, 3-PPP and RDS-127 on substantia nigra neurons
1984
effect of phencyclidine and other psychomotor stimulants in serotonin uptake in human platelets
1980
The Inhibition of Liver Ribonucleic Acid Synthesis by Ethionine
1966
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?
1987
Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (−)-3-PPP by recording of yawning behaviour in rats
1984
A Mild, Nonbasic Synthesis of Thioethers. The Copper-Catalyzed Coupling of Boronic Acids with N-Thio(alkyl, aryl, heteroaryl)imides
2002
3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors
1981 StandoutNobel
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
Dopamine-receptor agonist with apparent selectivity for autoreceptors: a new principle for antipsychotic action?
1982 StandoutNobel
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Age-related behavioral and neurobiological changes: A review with an emphasis on memory
1981
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity
1982
Treatment of Depression in Chronic Cocaine and Phencyclidine Abuse With Desipramine
1986
Reduction in temporal lobe size in siblings with schizophrenia: A magnetic resonance imaging study
1990
Clinical Effects of Apomorphine in Schizophrenia
1984
An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system
1985 StandoutNobel
The effect of ethionine on the synthesis of β-galactosidase: Formation of an immunologically cross-reacting protein
1969
Host specificity of DNA produced by Escherichia coli
1970 StandoutNobel
DNA Methylation and Gene Function
1980 StandoutScience
The role of serotonin in the pathophysiology and treatment of schizophrenia
1997
Quantitative magnetic resonance imaging of the brain in late-life schizophrenia
1995
Evidence for ethylation of rat liver deoxyribonucleic acid after administration of ethionine
1971
Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain.
1988
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
1980 Nature
Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens
1983
Antioxidant defenses and lipid peroxidation in human blood plasma.
1988 Standout
Works of Robert C. Smith being referenced
Hyperglycemia associated with the use of atypical antipsychotics.
2001
The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia
2001
Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients
2005
Clinical and Neurocognitive Effects of Clozapine and Risperidone in Treatment-Refractory Schizophrenic Patients
1998
Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia
2005
Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia
1985
Blood Levels of Neuroleptic Drugs in Nonresponding Chronic Schizophrenic Patients
1979
Asymmetries in the densities of white and gray matter in the brains of schizophrenic patients
1983
Stimulation of incorporation of formate-14C into the adenosine nucleotides of the liver of ethionine-injected rats
1969
Central catecholamine neurons, behavior and neuroleptic drugs: An analysis to understand the involvement of catecholamines in schizophrenia
1974
Behavioral evidence for supersensitivity after chronic bromocriptine administration
1979
Antioxidant properties of 2-imidazolones and 2-imidazolthiones
1987
Oxidation Of Thiols By Copper(II)
1994
The first dissociation constant of uric acid
1988
Effect of age on adrenergic and dopaminergic receptor binding in rat brain
1980
Uric acid protection of nucleobases from ozone-induced degradation
1986
Nuclear magnetic resonance in schizophrenia: A preliminary study
1984
Comparative effects of d-amphetamine, l-amphetamine and methylphenidate on mood in man
1977
Schizophrenic Symptoms Improve with Apomorphine
1978 Science
Haloperidol
1984
Effects of dopamine agonists in tardive dyskinesia
1977
Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain
1977
Effect of apomorphine on schizophrenic symptoms
1977
Enhancement by Adenine of the Inhibition of Salmonella typhimurium by Ethionine
1965
Effect of Ethionine on the Ribonucleic Acid, Deoxyribonucleic Acid, and Protein Content of Escherichia coli
1965
Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics
1987
Magnetic resonance imaging studies of the brains of schizophrenic patients
1987
Lateral ventricular enlargement and clinical response in schizophrenia
1985
The Interpretation of Plasma Haloperidol Concentrations-Reply
1985
Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine
1976
Formation of S-adenosylethionine by ethionine-treated rats
1965
Normal Ureter Size on Unenhanced Helical CT
2004